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Characterized by social impairments, repetitive or compulsive behaviors, and 
speech deficits, the underlying causes of Autism Spectrum Disorder (ASD) are 
currently unknown. Both oxytocin and arginine vasopressin are involved in 
regulating social behaviors in mammals and the dysregulation of each is thought 
to play a role in social impairments associated with ASD. Studying the secretion 
dynamics of these peptides can help us better understand regulatory 
relationships that may be involved in neurodevelopmental disorders like ASD.  
Microfluidic brain slice culture is an important tool for ex vivo modeling of basal 
and diseased state neurochemistry. A significant challenge to culturing brain 
slices in microfluidic flow systems is the efficient delivery of oxygen to enable 
medium to long-term viability of tissue slice. A microfluidic slice culture device 
that delivers continuous flow of carbogen gas-segmented culture media droplets 
to an immobilized brain tissue slice for total perfusion, enabling efficient 
oxygenation has been developed. The size of tissue slices, and the dimensions 
of the required tissue chamber present a lower limit of droplet volume on the 
order of 10 μL, which is a relatively large volume compared to many microfluidic 
systems. For downstream assay of cellular secretions, sample preconcentration 
is needed. An electrophoretic platform for sample preconcentration within the 
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CHAPTER 1. INTRODUCTION 
1.1 Autism Spectrum Disorder 
Autism Spectrum Disorder (ASD) is a developmental disorder characterized by 
abnormal social interaction, repetitive or compulsive behaviors, speech deficits, 
and restricted interest.1,2 Presentation of autistic features varies and can range 
from mild to severe.3 Individuals also show varying cognitive development, 
ranging from those who function well above average to those who show 
intellectual disabilities.3 The Centers for Disease Control and Prevention has 
been tracking the prevalence of ASD since 1996 through the Autism and 
Developmental Disabilities Monitoring (ADDM) Network. In 2016, the combined 
ASD prevalence, with data from all ADDM sites, was one in 54 children aged 8 
years.4 While ASD is a disorder with strong genetic correlations, no single 
genetic mutation accounts for more than 1-2% of ASD cases.2,5 Assessment of 
chromosomal variations, as well as other gene related studies have shown a 
wide range in genes with predisposing mutations and polymorphisms associated 
with ASD.2 Neuroanatomical studies, one of the various approaches used to 
study the underlying mechanisms of ASD, have reported abnormal neuronal 
connectivity in autistic individuals.2 While the scientific community struggles to 
identify the key neurophysiological mechanisms of ASD, the neuroendocrine 
mechanisms involved are relatively less studied.  
1.1.1 Neuropeptides of ASD 
Oxytocin and arginine vasopressin. Oxytocin (OT) is a hormone that is 
synthesized by the magnocellular neurons of the supraoptic (SON) and 
paraventricular (PVN) nuclei within the hypothalamus.6,7 OT helps induce the 
production of milk and facilitate uterine contractions during childbirth.7 Arginine 
vasopressin (AVP) is a peptide, also synthesized in both the SON and PVN, that 
regulates the tonicity of body fluids by increasing the amount of solute-free water 
reabsorbed by the kidneys, which is then returned to the vascular system.8 In 
addition to being produced in the same nuclei of the hypothalamus, OT and AVP 
are also similar in structure. Both neuropeptide structures consist of a six amino 
acid ring with a three amino acid tail, and only differ by two amino acids, in the 
third and eighth positions (Figure 1-1).9–11 These neuropeptides are released into 

















Figure 1-1. Neuropeptides of ASD. Diagram of oxytocin and arginine vasopressin, 
showing the differing amino acids at the third and eighth positions. Full chemical 














There has been high interest in the neuropeptides OT and AVP in ASD because 
of their role in social and affiliative behavior in animals.13,14 Extensive research 
has been conducted and animal studies have shown that both OT and AVP 
influenced deficits in social and communicative behaviors. For example, Winslow 
et al. demonstrated how the administration of OT and AVP in infant mice reduced 
distress calls.14 OT has been shown to reduce natural avoidance of proximity and 
inhibit defensive behavior and AVP has been linked to social behaviors such as 
aggression, scent marking and courtship.11,15 Though studies have shown the 
implications of OT and AVP in ASD, there is a critical need to better elucidate the 
neuroendocrine mechanisms of ASD. 
 
Dynorphins. Dynorphins are a class of opioid peptides produced and secreted by 
magnocellular oxytocin and vasopressin neurons.16 This class of opioid peptides 
includes dynorphin A, dynorphin B, and α/β-neo-endorphin,  and arises from the 
precursor protein prodynorphin when it is cleaved by proprotein convertase 2 
(PC2).17 Dynorphins are found widely distributed throughout the central nervous 
system,  but have the highest concentrations in the hypothalamus, medulla, 
pons, midbrain, and spinal cord.18 They work at kappa opioid receptors and have 
been linked to anxiety like behavior and negative emotional states.19,20 They are 
also present in the same magnocellular nuclei responsible for synthesis of OT an 
AVP and have been shown to inhibit OT and AVP secretion.21,22 While most 
knowledge in regards to the ability of OT and AVP to regulate social interactions 
is based on data from animal models, preliminary studies suggests that similar 
social and stress related effects are present in humans.7,23 The importance of OT 
and AVP in stress and in social interactions has been established, suggesting 
that dysregulation of both may be associated with disorders and psychosocial 
relevance like ASD. To better understand the regulatory relationships of OT, 
AVP, and dynorphin new analytical tools are needed for modeling secretion and 
measuring biologically relevant concentrations in ex vivo models.  
1.2 Microfluidics for Brain Slice Culturing    
The culturing of organotypic brain slices can preserve brain structure and 
maintain the functionality of neurons within the sliced region while allowing 
control of the extracellular environment.24,25 These ex vivo models are 
established tools to study basal and diseases state neurochemistry.26 
Conventional chambers used to culture organotypic brain slices, include interface 
chambers, which supply a high concentration of oxygen directly to the slice from 
above, and submerged chambers, where slices are surrounded completely by 
hyper oxygenated artificial cerebrospinal fluid (aCSF). However, these chambers 
do not maintain effective nutrient/waste turnover or uniform oxygen 
exchange.25,27 Viability of the brain slice is dependent on the diffusion of oxygen 
into the slice which is limited by the thickness of the tissue.25 The flow of oxygen 
and nutrients around the slice is optimal for delivery but is limited by a thickness 





enhanced brain slice viability by improving oxygen and nutrient penetration into 
slices.25 Hill et al. demonstrates how the efficiency of the nutrient and oxygen 
exchange is improved by actively flowing aCSF around the tissue.27 This causes 
aCSF to be “pushed” or “pulled” through the slice, increasing oxygen availability, 
thereby improving viability.27  
1.3 Electrophoresis 
Electrophoresis is the movement of charged molecules through a conductive 
aqueous medium under the influence of an electric field generated by 
electrodes.28 Sample is introduced at the anode and flows toward the cathode, 
while molecules within the sample have different migration times depending on 
the size of ions and magnitude of charge. Cations migrate towards the negatively 
charged electrode while anions migrate towards the positively charged electrode 
with the rate of ion migration depending on the charge-to-size ratio. Ions with 
higher charge will migrate faster than ions with a lower charge that are the same 
size and smaller ions will migrate faster than larger ions with the same charge. 
Neutral molecules are not affected by the electric field.   
 
The bulk flow of buffer solution under the influence of the electric field is known 
as electroosmotic flow (EOF).28 The phenomenon is due to the formation of an 
electric double layer on the inner surface of the separation channel. For example, 
in capillary electrophoresis, the wall of the capillary has an excess charge due to 
ionization or the adsorption of ionic species at the surface. A capillary wall coated 
with fused silica has a surface made of silanol groups. The silanol groups are 
ionized to negatively charged silanolate groups that will attract cations from the 
run buffer and form an inner layer of cations at the wall of the capillary, known as 
the fixed layer.28 All the negative charges on the capillary surface are fully 
neutralized by the formation of a mobile layer of cations, that is not tightly held 
because it is further away from the silanolate groups. Due to the presence of 
both the fixed and mobile layers, a diffuse double layer of cations forms. The 
cations present in the diffuse layer carry the bulk of the buffer solution with them 
in the presence of an electric field, leading to the formation of EOF. 
 
The electrical imbalance that is generated between the fixed and mobile layers is 
known as the zeta potential (𝜉).29 The EOF is proportional to the zeta potential 







where E is the applied electric field, 𝜀 is the dielectric constant, and 𝜂 is the 
viscosity of the buffer.29 Unlike the velocity of the EOF, the electroosmotic 
mobility is independent of the applied electric field and only depends on the 












1.4 COMSOL Multiphysics 
COMSOL Multiphysics is a cross-platform finite element analysis (FEA) solver 
and Multiphysics simulation software. FEA is a numerical method used to solve 
problems of engineering and mathematical models, expressed as partial 
differential equations, using an array of mathematical techniques.30 It allows a 
representative model of a real-life object to be developed and that model can be 
used to make observations about what that object would do when met with a 
specific boundary condition. A problem is split into smaller, simpler parts; a finite 
number of elements. Equations that model these finite elements are solved and 
assembled back into the larger system of equations that model the entire 
problem.31 
 
FEA is governed by the principle of minimization of energy.30 When certain 
boundary conditions are applied to a model there are several configurations but 
only one configuration is realistically possible. Due to the principle of 
minimization of energy, the only configuration realistically possible is one where 
the total energy is minimum.  
 
Designed for real-world applications, the COMSOL Multiphysics simulation 
environment is used to mimic effects that can be observed in the real world. In 
order to set up and run a simulation, users follow a general modeling workflow 
regardless of the physics being used or problem being solved. This workflow 
consists of seven steps: setting up the model environment, building the 
geometry, specifying material properties, defining physics boundary conditions, 
creating the mesh, running the simulation, and postprocessing the results.  
 
When first opening the COMSOL application on the desktop, the software will 
prompt the user to set up the model environment by choosing between the model 
wizard or a blank model. The model wizard is a guided approach recommended 
for all users, regardless of experience and background. Next the user is 
prompted to select the dimensional space of the model as well as the physics 
interfaces that will used. A wide variety of physics interfaces such as acoustics, 
electrochemistry, heat transfer, fluid flow, and more are available to simulate. 
Commonly known Multiphysics, such as joule heating, are automatically pre-
coupled with all the appropriate physics when selected but multiple physics can 
be coupled as needed by the user manually. To complete the setup of the model 
environment, the user is prompted to select the type of study to apply to the 





Users can choose from the general studies to determine whether the model will 
be time dependent or stationary or preset studies for the previous selected 
physics interfaces can be used.  
 
The next step of the workflow is building the geometry. There are many drawing 
tools and operations built into the COMSOL software that can be used to create 
needed geometries. It is also possible to import geometries from external files or 
sync geometries from design software like AutoCAD through the purchase of 
add-on products. Once the model geometry is built the materials of the model 
and their properties can be specified. There are several built in materials 
provided by the software that can be selected. It is possible to design a model 
made of various materials by adding specified materials to separate components 
that compose the model. Depending on the materials and physics selected there 
may be material properties that need to be defined by the user in order to 
compute the problem. Material properties tied to physics are indicated by the 
software. 
 
Once the geometry is built and the material proprieties have been specified, the 
next step is to define the physics. Mathematical equations can be assigned to the 
model or parts of the model in order to simulate the physics. This is done by 
selecting different parts of the geometry and the specifying appropriate equations 
and physical conditions that describe that part. The equations representative of 
any of the physical conditions used within COMSOL Multiphysics can be seen by 
the user and boundary conditions and constraints can be added and changed 
from the default values as needed. 
 
When all of the boundary conditions and constraints have been defined for the 
model, the next step is to create a mesh. Users have the choice between a 
custom mesh, where physics of the model can be removed and not taken into 
account when the mesh is generated, or the automatically generated mesh, 
which is adapted to the physics settings within the model. User can choose from 
shapes, such as triangles, quadrilaterals, tetrahedrons, hexahedrons, pyramids 
and prisms when manually generating a mesh. Size choices also range from 
extremely fine to extremely course, making a mesh completely customizable.  
 
The next step in the workflow is to run the simulation. The software will 
automatically generate plots based on the physics selected in the model. The full 
Multiphysics problem being computed can be reviewed and edited by the user in 
the study before the model is computed. Once the model is computed the results 
can be postprocessed. Immediately after solving, a default plot appears. Existing 
plots can be modified, or new ones can be created. For example, a plot showing 
temperature could be easily changed to display voltage or a completely arbitrary 






CHAPTER 2. MICROFLUIDIC BUBBLE PERFUSION DEVICE 
2.1 Introduction       
Microfluidic devices have been shown to improve the efficiency of brain slice 
culturing by improving oxygen and nutrient delivery to tissues. However, the 
continuous flow of aCSF used in these types of devices does not allow for time-
resolved measurements of tissue secretions that contain biological molecules of 
interest due to the diffusional mixing of analytes between the time of secretion 
and collection of the perfusate samples. Correlating neuropeptide secretion 
changes in the brain with behavior requires high temporal resolution on the 
seconds timescale. The generation of monodispersed aCSF droplets ensures 
that the brain slice spends equal amounts of time in media and oxygen thereby 
improving the exchange. Individual droplets also allow for time resolved sampling 
by providing information about the brain tissue through the molecules secreted 
and collected within a droplet during a certain point in time. By keeping the 
droplets separated, even when they are analyzed downstream, a high-resolution 
secretion profile is obtained. 
 
Our lab has begun the development of a microfluidic perfusion device designed 
to enable time-resolved measurements of secreted factors while maintaining high 
efficiency tissue oxygenation. My colleague, Amirus Saleheen, has developed 
the microfluidic perfusion device, seen in Figure 2-1, that provides continuous 
droplets of aCSF segmented with carbogen gas to a chamber containing the 
brain tissue slice. As droplets enter the chamber and pass over the tissue slice, 
biological molecules are secreted and carried away with the droplet to be 
collected and analyzed further downstream. Droplets of aCSF are segmented 
with carbogen gas by the use of a microfluidic T-junction. In what is known as the 
squeezing regime, an emerging bubble fills most of the channel and a carrier 
liquid pushes the dispersed phase forward until it cuts off. Garstecki et al. 
investigated the formation of segmented droplets via the squeezing regime and 
showed the size of droplets or bubbles is determined by the ratio of the 









where 𝐿$ is the length of the dispersed segments, W is the width of the side 
channel,  𝑄$'() and 𝑄*+,- are the volumetric flow rates of the dispersed and 
continuous phase, respectively, and are constants that depend on the geometry 
of the T-junction.32 The monodispersed droplets and bubbles produced ensures 
the brain tissue slice spends an equal amount of time exposed to aCSF and 
carbogen gas, maximizing oxygen and nutrient exchange, while also allowing for 





To prevent the carryover between droplets that was periodically observed when 
part of a droplet broke off and was left behind in the chamber, droplet volumes 
need to be greater than 50% of the chamber volume and surfaces within the 








Figure 2-1. Original microfluidic perfusion device. Original device with T-junction 
demonstrating squeezing regime showing a droplet’s a) filling of the junction b) 














2.2 Materials & methods 
2.2.1 Materials and reagents 
Agarose, fluorescein disodium salt, sodium chloride, potassium chloride, 
disodium phosphate, monopotassium phosphate, Sylgard® 184 silicone 
elastomer base and curing agent, and acetone were purchased from Thermo 
Fisher Scientific (Waltham, MA). GelBond® film was purchased from Lonza 
(Morristown, NJ). A miniature pneumatic solenoid valve (model no. 20) was 
purchased from Parker Hannifin Corporation (Cleveland, OH). All 3D printing was 
done with the Anycubic Photon S LCD-based SLA 3D printer from Anycubic 3D 
printing (Commerce, CA). LabVIEW (National Instruments, Austin, TX) was used 
to automate the system. ImageJ (National Institutes of Health, Bethesda, MD) 
was used for image analysis.  
2.2.2 Droplet Generation 
Method 1.0. Continuous flow of aCSF droplets segmented with carbogen gas 
improves oxygen and nutrient exchange into brain tissue slices while also 
allowing for time resolved measurement of perfusate droplets. However, 
perfusion volumes are dependent on flow rates of these droplets. The volume of 
a droplet is dependent on its length and width, both dimensions which are directly 
proportional to the ratio of flowrates of carbogen gas and aCSF in the squeezing 
regime used to produce these droplets. Reducing the volume of perfusate 
droplets would decrease the dilution of secreted biological molecules. The T-
junction used in the previously developed microfluidic device was replaced by a 
single inlet connected to a miniature pneumatic solenoid valve. A waveform 
generator was used to supply 5V square wave pulse in order to power the valve 
and a n-channel metal-oxide-semiconductor field-effect transistor (MOSFET) was 
used in a circuit constructed to control the valve. Unlike like the squeezing 
regime used previously, the duty cycle of the square wave signal was easily 
manipulated to change the size of the bubbles and droplets. By using a duty 
cycle of 50% and making the flowrates of the gas and buffer equivalent, droplets 
and bubbles of equal volume were produced as seen in Figure 2-2. The pressure 
of the gas was set using the regulator valve on the tank then using the tubing 







Where ∆𝑝 is the pressure loss, 𝜇 is the dynamic viscosity, L	is the length of the 
tubing,	Q	is the volumetric flowrate and	r	is the radius of the tubing. The pressure 
needed for the buffer to match the flowrate of the gas was then calculated by 
plugging in the flowrate of the gas and solving for the ∆𝑝. Hydrostatic pressure 
was used to create the equivalent flowrate for the buffer, allowing droplets and 









Figure 2-2. Droplet Generation. Continuous flow of droplets and bubbles generated 

















Method 2.0 To reduce the volume of droplets even further, a new method to 
introduce the droplet to the slice in the chamber was developed. This droplet 
delivery protocol enabled control of single droplet generation, effectively 
decreasing perfusion volume. Using a LabView program, a DAQ, and multiple 
solenoid valves, the entry of droplets and bubbles into the chamber was 
controlled, instead of continuously flowing. Using separate channels, the valve 
connected to a syringe containing aCSF is opened and a droplet is pushed 
through the channel to the chamber housing the tissue slice. That valve is then 
closed, stopping flow and effectively holding the droplet in the chamber until flow 
is started again. Next, the valve connected to the gas cylinder containing the 
carbogen gas is opened and a bubble flows through the channel to the chamber, 
pushing the droplet out. The valve is then closed, stopping flow and leaving the 
slice in the chamber surrounded by gas. All valves are connected to a simple 
switch circuit programmed to send a 5V signal for a fixed amount of time to open 
and close the corresponding valve at the touch of a button. By controlling when 
and how long either aCSF or carbogen is flowing through the perfusion device, 
the volume of the droplet can be reduced to the minimum volume needed to fill 







Figure 2-3. Droplet delivery. Frame by frame of a) a droplet entering the channel when 
the buffer valve is open b) flow stopping and the chamber being filled when the buffer 
valve is closed c) a droplet being pushed out of the chamber by a bubble when the gas 








2.2.3 Device Fabrication 
Chip 1.0 Holes were carefully drilled into a glass microscope slide for the inlets 
and outlets of the channels. Another microscope slide was then heated to 
approximately 300℃ over an open flame before the channels were etched into 
the surface of the glass using a laser-cutter. Once the channels were etched into 
the surface the microscope slide was transferred from the open flame to a hot 
plate where the temperature was maintained at 300℃ for at least 20 minutes. 
The hot microscope slide was then transferred to the oven to slowly cool down to 
room temperature overnight. The cooled microscope slide and the microscope 
slide with holes drilled into it were then plasma cleaned and aligned to form an 
airtight seal.  
 
Chip 1.1 A mold of the same channel design as chip 1.0 was created in AutoCAD 
and 3D printed using the Anycubic Photon S 3D printer. Polydimethylsiloxane 
(PDMS) was then created using Sylgard 184. A 10:1 mixture of base elastomer 
to curing agent was poured into the 3D printed mold. To remove any air bubbles 
from the mixture, the mold was placed in a vac and left to set overnight. 
 
Chip 1.2 A two rectangles with the dimensions of a standard microscope slide 
were laser-cut from poly(methyl methacrylate) (PMMA). Holes for inlets and 
outlets were drilled into the first piece while channels were etched into the 
second piece using the laser-cutter. A couple of drops acetone were added to the 
surface of each PMMA then they were aligned and clamped together with large 
binder clips until the acetone evaporated and a seal formed. 
 
Chip 2.0 The same method was used as for chip 1.2, except all channels meet at 
a right angle, to reduce mixing of buffer and stimulant, rather than an angle less 
than 90° as seen in previous chips. The channel measure approximately 
500µm	wide and 300µm deep (Figure 2-5). 
 
Chamber Housing. The chamber that houses the brain tissue slice was made of 
a combination of VHB tape and GelBond®. Two layers of VHB tape were 
combined to make the total height of the chamber approximately 3mm. The 
chamber was then laser-cut into the VHB tape. The cut tape was applied directly 
to the surface of the chip after aligning the inlets and outlets of the channels and 
chamber. GelBond® was added to the top of the chamber, with the hydrophilic 





















Figure 2-4. Fabricated microfluidic devices. a) chip 1.0 made using glass microscope 
slides b) chip 1.1 made of PDMS sitting in the 3D printed mold c) chip 1.2 made of 

















Figure 2-5. Microfluidic bubble perfusion device. Schematic of chip 2.0 with the chamber 






2.3 Results & discussion 
2.3.1 Droplet Generation 
Method 1.0 Using a single solenoid valve at a single inlet to generate droplets 
and bubbles did allow for smaller volumes and proved to be superior to the 
original T-junction and squeezing regime, however, the method only worked 
when using phosphate-buffered saline (PBS). When using 100uM fluorescein in 
PBS buffer the droplets were no longer monodispersed at smaller volumes. The 
observed irregularity of the fluorescein droplets, seen in Figure 2-6, is likely due 
to the size and charge of the organic dye. The droplets seemed to be “sticking” to 
the walls of the tubing when leaving the valve and before entering the channel. 
This suggests that the fluorescein added to the solution increased the overall 
dynamic viscosity of the fluid. This increase in dynamic viscosity makes the 
fluorescein droplets more resistant to the pressure used to drive flow from the 
solenoid valve through the tubing. The pressure is great enough to readily 
overcome this resistance at the tubing’s axis more so than at the walls so 
droplets “stick” as these forces compete, until there is enough buildup of 
pressure to push the fluid some distance. The flowrate of the liquid versus the 
gas could have been calculated with this new dynamic viscosity and the setup 
could have been adjusted account for this but this method was not pursued 




























flowrates were corrected and the monodispersed droplets achieved with just PBS 
were duplicated, a new method was developed that reduced droplet volume even 
further. This new approach was ideal because future experiments would involve 
fluorescein and other organic molecules in order to image the system and verify 
slice viability in the chamber. Eliminating the use of a single solenoid valve 











Figure 2-6. Fluorescein droplets. Small volume droplet of 100uM fluorescein in PBS 









Method 2.0 The whole system was automated using LabVIEW and continuous 
flowing droplets were replace by single droplets delivered at a specified time. 
This method reduced the overall droplet volume because the minimum droplet 
volume needed is dependent on the chamber volume. Previous work showed 
that droplet volumes need to be greater than half the chamber volume and the 
chamber surface should be mostly hydrophilic to prevent droplets from breaking 
up in the chamber and being overtaken by the next droplet. A comparison of 
chamber shape, size and surface can be made to optimize the tissue slice 
housing. Square, diamond, and oval chamber shapes were designed in three 
varying sizes that would each be able to house a suprachiasmatic nucleus 
(SCN), hypothalamic, or whole mice brain slice. The contact angles of a water 
droplet on the surface of various materials were also measured. The 
effectiveness of any combination of all of these factors could be test by passing a 
single fluorescent droplet through the chamber, followed by droplets of buffer. 
The fluorescence intensity of the buffer droplets could be measured to quantify 
how much carryover is left between droplets. The ideal combination of chamber 
shape size and surface tension would have the least amount of carryover or the 
lowest measured fluorescence intensity.  
 
Keeping droplets segmented by bubbles is important in obtaining temporal 
information from the molecules secreted by the tissue slice. By reducing the 
chamber size to the minimum volume needed to house a specific size brain 
tissue slice, the volume of a single droplet can also be reduced, and the dilution 
of the molecules secreted into media is limited. 
2.3.2 Device Fabrication 
Though the small volume channels of chip 1.0 were desirable to the overall 
design of this microfluidic device, they were not functional. The back pressure 
within the channels was so great that it was impossible to pump droplets into the 
device even when using a syringe pump. The fabrication process was also 
tedious and yielded less than 50% of viable chips. This was due to the glass 
frequently cracking while cooling to room temperature from experiencing thermal 
stress. While the glass was heated close to its melting point in an attempt to 
reduce its amorphous nature, the cooling process still happened too quickly. The 
rapid changes in temperature induced stress on the surface of the glass chips 
and cause cracking along the etched channels.  
 
The PDMS mixture used to make chip 1.1 never set properly after numerous 
attempts. The polymer remained tacky and never fully solidified. This is thought 
to be a result of the 3D printed mold inhibiting the PDMS from curing properly 
due to compounds in the resin, such as uncured monomers and photo-initiators, 
leaching from the printed parts. Strategies to overcome this limitation, such as 





problem.33 However, this method was not pursued further because smaller 
channel dimensions were possible through other fabrication methods.  
 
While PMMA is sometimes called acrylic glass, it is a tough plastic polymer used 
as a glass alternative. Unlike glass, channels could be etched into the surface of 
the PMMA without heating or cracking the material because it has a much lower 
melting point and does not experience the same thermal stress. Chip 1.2 and 2.0 
were easily reproduced and the whole fabrication process could be completed in 
less than an hour. Droplets were easily flowed through the channels and the 
chips were reusable. The chamber housing could easily be placed on and 


































CHAPTER 3. COMSOL SIMULATIONS FOR UNDERSTANDING 
LATERAL ELECTROPHORESIS 
3.1 Introduction 
Electrophoretic methods such as isoelectric focusing and isotachophoresis have 
been used for sample enrichment in capillary electrophoresis, as well as in 
microfluidic devices.34,35 Generally, in these electrophoretic preconcentration 
techniques, the capillary is divided into sections by a discrepancy in a property, 
like pH or conductivity of solution.34 Long sample bands can be compressed into 
narrow, concentrated zones, by choosing appropriate conditions to manipulate 
analyte migration times in the capillary.34  
 
In the developed microfluidic bubble perfusion device, the size of the tissue 
slices, and the dimensions required to house the slice in the chamber present a 
lower limit of droplet volume on the order of 10µL. In order to increase the 
concentrations of molecules of interest within perfusate droplets and improve 
downstream assay of cellular secretions, sample preconcentration is needed. An 
electrophoretic preconcentration method was developed to be incorporated into 
the microfluidic bubble perfusion device. 
 
The developed electrophoretic platform utilizes platinum electrodes inserted in 
the sides of the channel within the microfluidic device. An electric potential is 
applied to the electrodes and as the perfusate droplets flow down the channel 
and through the electrodes, molecules concentrate at the electrode of opposite 
charge via lateral electrophoresis. The concentrated molecules at either 
electrode are separated further down the channel, reducing the overall volume. 
Proof-of-concept experiments were completed using 100 μM fluorescein in PBS. 
Platinum electrodes were integrated into the walls of the flow channels, and 
initially electric fields of 4, 8, 24, and 40 Vcm-1 were applied. In Figure 3-2, the 
buffer solution can be observed boiling in the channel due to joule heating before 
any separation occurs in electric fields higher then 4 Vcm-1. Two Peltier coolers 
were stacked and placed directly below the channel of the microfluidic device in 
order to combat the effects of joule heating. The experiments were repeated and 
electric fields from 30 to 50 Vcm-1 were reached with no signs of joule heating. 
Fluorescence imaging was used to confirm the concentration of fluorescein to 
one side of the channel by comparing the fluorescence intensity across the 
channel before and in between the electrodes. Images showed fluorescein 
concentrating at the negatively charged electrode. Fluorescein is a negatively 
charged molecule and therefore was expected to be observed concentrating at 
the positively charged electrode. It is hypothesized that the smaller anions and 
cations present in the buffer migrate through the electric field and to the 
electrodes at a much faster rate than the larger fluorescein molecules, causing 





In Figure 3-2, 100 μM fluorescein was flowed continuously through the channel of 
the developed electrophoretic platform. As the electric field was increased, the 
solution could be observed boiling in the channel due to joule heating. This was 
corrected with Peltier coolers, used to reduce the overall temperature in the 
channel while an electric field is applied. In Figure 3-3, droplets are seen flowing 
through the channel with and without the Peltier coolers. Without the 
thermoelectric cooling devices, most the solution is boiled of before exiting the 
channel, whereas, with the devices, no boiling is observed within the channel, 
even when a higher electric field was applied.  
 
In Figure 3-4, 100 μM fluorescein was flowed through the channel that is being 
cooled by Peltier coolers. The use of the Peltier coolers keeps the channel at low 
temperatures, preventing joule heating and allowing higher electric fields to be 
applied. Images of the fluorescein flowing through the channel were obtained and 
analyzed using ImageJ. By measuring the relative fluorescence intensity of the 
channel, the accumulation of fluorescein at the electrode was confirmed. Surface 
plots show high fluorescence intensity on the right side of the plot, which 
corresponds to the concentration of fluorescein flowing through the channel 
before reaching the electrodes. The left side of the surface plots only show 
fluorescence intensity towards the top plot corresponding with the accumulation 
of fluorescein on the top electrode. In all three of the electric fields shown, the 









Figure 3-1. Schematic of electrophoretic platform. Schematic with cross section of 





















Figure 3-2. Original lateral electrophoresis experiment.100 μM fluorescein flowing 
continuously through the electrophoretic channel from right to left in electric fields of a) 4 





























Figure 3-3. Thermoelectric cooling. Droplets of 100 μM fluorescein in an electric field of 
50 Vcm-1 a) entering the channel b) entering the electric field c) exiting the channel, 
without Peltier coolers; d) entering the channel e) entering the electric field f) exiting the 























Figure 3-4. Lateral electrophoresis with Peltier coolers. 100 μM fluorescein flowing from 
right to left in a) 30 Vcm-1 b) 40 Vcm-1 c) 50 Vcm-1 electric fields with Peltier coolers to 
correct joule heating. The dashed red line shows the area of the image used to make the 














Lateral electrophoresis was then simulated using COMSOL Multiphysics in an 
effort to better understand the observed behavior of these molecules and 
recreate the ion concentration polarization seen within the channel. When solving 
any problem using EOF in COMSOL, electric currents or electrostatics, creeping 
or laminar flow, and transport of diluted species are the three main physics 
involved in the simulation. Each solves for the potential, velocity and pressure, 
and concentration, respectively. The electric currents or electrostatics interfaces 
are similar, both requiring an electric potential to define and electric field (Eq 5). 
 




 The equations in the electric currents interface are formulated with electrical 
conductivity(𝜎) (Eq. 6) and using boundary conditions, the electric potential can 
be specified at different locations to make electrodes with defined voltage, 
current, or power applied to drive the fluid motion.  
 




Creeping or laminar flow is determined by the Reynolds number being greater 
than or less than one. The Reynolds number gives the ratio of inertial forces to 







   
Where the inertial force is 𝜌, the density of the fluid, 𝑢0, the velocity of the fluid, 
and 𝐿, the width of the channel and 𝜇 is the dynamic viscosity of the fluid. When 
the Reynolds number is less than one the inertial force becomes negligible 
allowing the term to be ignored when solving for the Navier-Stokes equation. The 












When using electroosmotic flow the inlets and outlets are defined as having an 





relative permittivity (∈1) are used to calculate the electroosmotic velocity (𝑢(2')) at 








 The last physic, transport of dilute species, accounts for diffusion, convection 
and/or migration of the species. The Nernst-Planck Equation embodies all three 





𝑅𝑇 𝐷'𝐶'∇𝜙 + 𝐶'𝑣	
 
(10) 
Where is flux of the species, is the diffusion coefficient, is the concentration of the 
species, is the potential and is the velocity of the species. The first term is 
diffusion, the second term is migration and the third term is convection. 
Convection is just fluid motion carrying the species and is based on the fluid flow 
conditions from the creeping/laminar flow solution, so in the case of EOF the 
electroosmotic velocity from the creeping flow solution is carried to the 
convection term in Eq 10. 
3.2 Materials & methods 
3.2.1 Materials and reagents 
Fluorescein disodium salt, sodium chloride, potassium chloride, disodium 
phosphate, and monopotassium phosphate were purchased from Thermo Fisher 
Scientific (Waltham, MA). PDMS (250µm) was purchased from Stockwell 
Elastomerics (Philadelphia, PA). COMSOL Multiphysics simulations were 
performed using a Dell Precision Tower 7810 Workstation. ImageJ (National 
Institutes of Health, Bethesda, MD) was used for image analysis. 
3.2.2 Band Dispersion in EOF 
Using COMSOL Multiphysics, a model of the dispersion of a neutral species 
band in EOF moving through a curved microfluidic channel was simulated.  
Electric currents, creeping flow, and transport of diluted species were the three 
physics used to solve this problem. The velocity field from creeping flow was 
coupled to the transport properties and convection was the mechanism by which 







3.2.3 Simulating Electrophoresis 
The simulation used to study the dispersion of a neutral species band in EOF 
was used as a base model for simulating electrophoresis. The transport 
mechanism was changed from convection to migration in an electric field in order 
to assign a charge to species and another concentration was added. Differing 
charges were assigned to the two concentrations in order to observe an 
electrophoretic separation. All other physics remained the same as the original 
model. 
3.2.4 Simulating Lateral Electrophoresis 
From there, the same physics were used to simulate the phenomenon that was 
being observed in the electrophoretic channel. Properties, such as density, 
concentration, and relative permittivity, of PBS were plugged in as parameters in 
the simulation and an electric field of 50Vcm-1 was simulated to mimic the real-life 
experiments that were already conducted. A stationary and time dependent study 
was run for this simulation. 
3.3 Results & discussion 
3.3.1 Band Dispersion in EOF 
The velocity magnitude within the curved microchannel and be observed in 
Figure 3-5. It remains uniform in the straight paths of the channel but there is an 
increase in velocity on the inner curve and a decrease in velocity on the outer 
curve. This velocity gradient causes dispersion as the band of neutral species 
travels around the curve. Molecules closer to the inside of the curve are 
accelerated for a fraction of the migration time while molecules closer to the 
outside are decelerated. Even though the velocity once again becomes uniform 
further down the channel, after the curve, the band continues to disperse 
because molecules arrive to this uniform point in the channel at different times, 
as shown in Figure 3-6. 
 
The mechanism of transport of species for this simulation was convection. The 
species in this problem is neutral so it was not necessary to use migration in an 
electric field as the mechanism of transport. Even though it does not use a 
charged species, this simulation was used as the base model for simulating 








Figure 3-5. Velocity and electric potential. Surface plot of the velocity magnitude and 










Figure 3-6. Band dispersion. Neutral species band in EOF moving through a curved 





3.3.2 Simulating Electrophoresis 
In order to simulate electrophoresis, the same parameters and boundary 
conditions from the previous problem were used. The mechanism of transport 
was changed from convection to migration in an electric field in order to add a 
charge to the species. A second species with the same concentration and a 
different charge was added. The electric potential and velocity magnitude also 
remained the same as previously shown in Figure 3-5.  
 
Figure 3-7 shows two species, one with a negative charge and one with a 
positive charge, moving away from each other. The electric field carries the 
negatively charged species to the left while carrying the positively charge species 
to the right. In Figure 3-8, the two species are moving in the same direction, to 
the right, because they are both positively charged. However, the separation can 
still be observed because there is a difference in migration time due to the 
difference in magnitude of charge. The species with the charge of greater 








    
 
Figure 3-7. Electrophoretic separation 1.0. Species with -1, traveling to the left, and +1 




Figure 3-8. Electrophoretic separation 2.0. Species with +3 and +1 charge, both traveling 














The electrophoresis simulation happens on a larger time scale than the 
dispersion of the neutral species band. This suggests that pressure driven flow is 
a faster method for moving species through a microchannel. However, even 
when including species of differing charges, pressure drive flow does not yield 
the separation needed within the developed microfluidic device.  
3.3.3 Simulating Lateral Electrophoresis 
Using the same physics as the two previous simulations, the microchannel used 
in proof-of-concept experiments was modeled. The flow in the channel from right 
to left can be seen illustrated in the surface plot in Figure 3-9, as well as the 
electric potential from the 50Vcm-1 electric field. The whole channel was not 
modeled, instead just the portion right before the electrodes and slightly after the 
electrodes.  
 
When looking at the surface plot of the concentration from the stationary study, it 
initially looks as if there is no concentration in the channel at all. Upon closer 
inspection, zooming in on the electrode, the species can be seen concentrated 
on the surface of the negative electrode. For this simulation, the mechanism of 
transport is also migration in an electric field and the species observed in Figure 
3-10 was given a positive charge to simulate the cations within the buffer 
solution. The concentration of cations at the negative electrode in the stationary 
study of this simulation support the hypothesis that the charge ions within the 
buffer solution concentrate on the electrode of opposite charge, before the 
fluorescein molecules travels through the electric field. The time dependent study 
reflects this also, showing an increase in the concentration of cations at the 
negative electrode as time elapses. The slight depletion of concentration at the 
opposite electrode can also be observed. This suggest that if the charge of the 
species was reversed, it would concentrate at the opposite electrode and given 
two species with opposite charge, both electrodes would be an area of high 
concentration within the channel.  
 
The results of the simulation do not directly reflect what was observed in the 
initial lateral electrophoresis experiments. The ion concentration polarization that 
caused the fluorescein to concentrate at the electrode of the same charge is not 
demonstrated in this simulation. The movement of the buffer ions to the opposing 
electrodes is simulated, however, the electric field produced by these ions 
concentrating in solution is not accounted for. To simulate the whole process of 
ion concentration polarization, the electrostatic effects produced by the high 
concentration of buffer ions at the electrodes would need to be appropriately 
modeled. The transport of diluted species physics is limited in the fact that it 
models diluted species that may become concentrated after transport but not the 
effects after that concentration. This model could be divided into two parts where 
the resulting electric field could be estimated, since it is known that it is strong 





the buffer ions have concentrated but the accuracy of this second step could not 
be confirmed and would not be useful for predicting the behavior of other 














Figure 3-9. Flow profile and electric potential. Surface plots showing the velocity 





















Figure 3-10. Stationary study. Surface plot of concentration throughout the channel with 













Figure 3-11. Time dependent study. Surface plots showing the increase and decrease in 













CHAPTER 4. FUTURE DIRECTIONS 
Studying the secretion dynamics of neuropeptides enables better understanding 
of endocrine mechanisms and regulatory relationships that may be involved in 
neurodevelopmental disorders like ASD. Ex vivo brain tissue slices are a useful 
model for studying these mechanisms, but conventional culturing techniques are 
poorly suited for imaging or chemical analysis. The culturing of organotypic brain 
slices can preserve brain structure and maintain the functionality of neurons 
within the sliced region while allowing control of the extracellular 
environment.24,25 These ex vivo models are established tools to study basal and 
diseased state neurochemistry.26 
 
The typical microfluidic device used to culture these slices uses continuous flow 
of aCSF and does not allow for time-resolved measurements of tissue secretions 
that contain biological molecules of interest due to the diffusional mixing of 
analytes between the time of secretion and collection of the perfusate samples.  
The device developed in chapter 2, generates monodispersed droplets ensuring 
the tissue slice spends equal amounts of time in media and oxygen thereby 
improving the exchange while also allowing for time resolved sampling.  
 
Further development of both devices discussed in chapter 2 and 3 will deliver 
technologies that address existing shortcomings in the field of neuroendocrine 
characterization and brain tissue slice culture methodologies. With better 
understanding of the observe phenomenon in the developed electrophoretic 
channel, the preconcentration method can be incorporated to the microfluidic 
device developed in chapter 2. Successful integration will yield decreased 
dilution of sampled biomolecules in perfusate droplets for optimized downstream 
analysis.  
 
Once the generation and collection and perfusate droplets has been optimized 
an immunoassay can also be integrated into the microfluidic device. 
Fluorescence anisotropy immunoassays have been described previously as a 
means for separation-free assay of secreted peptide hormones.36 In this case, a 
separation-free approach is particularly attractive because it simplifies the 
integration of immunoassays with the segmented droplet flow system.  
 
In fluorescence anisotropy a fluorescent sample is excited with linearly polarized 
light, and the degree of depolarization upon fluorescence emission is quantified 
to determine the relative rate of molecular rotation (Figure 4-1). In a fluorescence 
anisotropy immunoassay, a fluorescently labeled analog of the analyte of interest  
would be  added to the sample solution along with the complementary antibody. 
The analyte of interest then competes with the fluorescently labeled analog to 
bind to antibody. With the increasing concentration of the analyte of interest,  
























in labeled analog-antibody complexes as a result of binding competition. Since 
the rate of rotation of the fluorescently labeled analog is much greater than that 
of the labeled analog-antibody complex, the degree of free vs. bound 
fluorescently labeled analog can be determined via fluorescence anisotropy.36 
Integrating the anisotropy immunoassay with the perfusion microdevice 
will require developing the microscope instrumentation. In this set up, excitation 
light is polarized via a polarizing filter before being subjected to the sample via 
conventional epifluorescence microscopy. Fluorescence emission is then 
collected and passed through a polarizing beam splitter to allow perpendicular 
polarized components to be detected at two separate photomultiplier tubes. The 










where I|| is the intensity of fluorescence emission with identical polarization to the 
excitation source and I⊥ is the intensity of fluorescence emission polarized 
perpendicular to the excitation source.36 
The relationship between the analyte of interest concentration and r  can be 
calibrated using commercially available standards in order to create standard 
curves to determine the concentration of each neuropeptides or other molecules 
of interest  in collected perfusate droplets. The future of this project will develop 
the technologies needed to measure the time-resolved secretion of these 
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Chemical structures of key molecules involved in this work 
 
 
Figure A-1. Arginine Vasopressin. Chemical structure of Arginine vasopressin with 
labeled amino acids 
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